RNAi-directed mRNA Cleavage
HSP90 alpha/beta siRNA and shRNA Plasmids (m)
- Target species: mouse; for corresponding human product, see HSP 90α siRNA and shRNA Plasmids (h)
- Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length
- For independent verification of HSP90 alpha/beta gene silencing results, individual duplex components or plasmids are also available upon request
- Suitable control antibody: HSP90 alpha/beta Antibody (F-8): sc-13119 is recommended as control antibody for monitoring of HSP90 alpha/beta expression knockdown by Western blotting or immunofluorescence
- Get details about si/shRNA Gene Silencers
- Gene silencers are intended for noncommercial and research use only. Click here for details.
QUICK LINKS
Ordering Information
siRNA
shRNA Plasmid
shRNA Lentiviral Particles
Recommended Control Antibody
SEE ALSO...
HSP 90β Antibodies for analysis of cellular responses to HSP 90β si/shRNA Gene Silencers
Description
- 10 µM, 50-100 transfections
- siRNA products generally consist of pools of three to five target-specific 19-25 nt siRNAs designed to knockdown gene expression
- for independent verification of HSP90 alpha/beta gene silencing results, individual siRNA duplex components are also available upon request
- suitable control antibody: HSP90 alpha/beta Antibody (F-8): sc-13119
- Primer is not available
- Get details about si/shRNA Gene Silencers
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 20 µg, up to 20 transfections
- shRNA Plasmids generally consist of a pool of three to five lentiviral vector plasmids each encoding target-specific 19-25 nt (plus hairpin) shRNAs designed to knockdown gene expression
- shRNA sequences correspond to HSP90 alpha/beta siRNA Gene Silencer sequences
- provided as transfection-ready purified plasmid DNA target-specific gene silencing
- after transfection, cells stably expressing shRNAs can be isolated by puromycin selection
- shRNA Plasmids are intended only for non-commercial use.
- suitable control antibody: HSP90 alpha/beta Antibody (F-8): sc-13119
- Primer is not available
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 200 µl viral stock containing 1x 106 infectious units of virus (IFU) , sufficient for 10-20 transductions
- Lentiviral Particles are provided as transduction-ready viral particles for gene silencing
- Lentiviral Particles generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression
- shRNA sequences correspond to HSP90 alpha/beta siRNA Gene Silencer sequences
- After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin
- Biosafety - Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
- Lentiviral Particles are intended for non-commercial use.
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HSP90 alpha/beta siRNA (m) | sc-35610 | 10 µM | $293.00 | |||
HSP90 alpha/beta shRNA Plasmid (m) | sc-35610-SH | 20 µg | $592.00 | |||
HSP90 alpha/beta shRNA (m) Lentiviral Particles | sc-35610-V | 200 µl | $711.00 |